Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
Steigende Produktionsmengen, operative Hebelwirkung und der Goldpreis könnten zusammen neue Impulse setzen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
37 Leser
Artikel bewerten:
(0)

Atrial Fibrillation Market to Exhibit 13.26% CAGR to 2021 as Catheter Ablation Drives the AFib Industry Growth

PUNE, India, October 18, 2016 /PRNewswire/ --

According to research report, Global Atrial Fibrillation (AFib) Market (Non-Surgical/Catheter, Surgical- Mini Maze, Hybrid): Analysis By Region, By Country (2016-2021F), the industry is projected to exhibit a CAGR of over ~13.26% during 2016 - 2021.

Complete report on Atrial Fibrillation (Afib) market spread across 124 pages, analysing 8 major companies and providing 3 tables and 79 figures is now available at http://www.rnrmarketresearch.com/global-atrial-fibrillation-market-non-surgical-catheter-surgical-mini-maze-hybrid-analysis-by-region-by-country-2016-2021f-by-procedures-surgical-ablation-mini-maze-hybrid-non-surgical-catheter-by-r-na-japan-market-report.html.

Market for Afib is growing steadily on account of the rising number of Afib cases, which is caused by the lifestyle related diseases, such as hypertension, diabetes, obesity, and is gaining prominence among both adult and aged population. Rising cases of atrial fibrillation (Afib) among the population along with the growing focus on catheter ablation procedures has led to the growth of atrial fibrillation market

Among the segments, market is expected to be driven by catheter ablation procedures on account of the technological improvement leading to higher success rates among the patients.

While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure, leading to increase in ablation centres and rising focus on healthcare among the growing middle class population.

Global Atrial Fibrillation Market is forecasted to grow at a CAGR of 13.26% during 2016 - 2021F, on account of rising Afib among the population. North America region remains the major market among all the regions. In the forecast period, APAC region will witness strong growth driven by the countries such as Japan and China. Order a Copy of Report at http://www.rnrmarketresearch.com/contacts/purchase?rname=723916.

Company profiling in this report are - St. Jude Medical, Medtronic, Boston Scientific Corporation, Atricure Inc., Cardiofocus Inc., Biosense Webster Inc., Biotronik and TZ Medical

Scope of the Report: The report provides Segmentation by Procedures: Surgical Ablation - Mini Maze, Hybrid; Non-Surgical - Catheter. The report provides coverage by Region: North America, Europe, Asia Pacific and ROW. The report provides coverage by Country: USA, Canada, UK, Germany, Japan and China.

Partial List of Figures and Tables provided in this research:

Table 1: Medicare Reimbursement for Endovascular and Open Ablation

Table 2: Medicare Reimbursement Rate for CY-2015& CY-2016

Table 3: 2015-2016 National Average Medicare Reimbursement

Figure 1: Global AF Ablation Market, By Value, Historic (2011-2015) in USD Billion

Figure 2: Global AF Ablation Market, By Value, Forecast (2016E-2021F) in USD Billion

Figure 3: Afib Patients in Western Europe in million

Figure 4: Afib Patients in United States in million

Figure 5: Global Afib Patients in million

Figure 6: The Benefit payable for MBS item number 38290 during 2011-12 & 2012-13

Another related report on Cardiovascular Device Market is Cardiac Medical Devices Market in the US 2016-2020; the analysts forecast cardiac medical devices market in the US to grow at a CAGR of 1.82% during the period 2016-2020. Atrial fibrillation (AF), a common type of heart arrhythmia, is a heart condition when the heart beats too fast or too slow or in an irregular way. An estimation done by the Centers for Disease Control and Prevention (CDC) in 2015 shows that in the US 2.7-6.1 million people were diagnosed with AF. It is most common in the older population, among people aged 60 years or above. This condition occurs when the heart's ability to function reduces and there is a malfunction in the electrical impulses in the heart, which leads to sudden cardiac arrest or heart failure. Key vendors: Boston Scientific, LivaNova, Medtronic and St. Jude Medical. Complete report available at http://www.rnrmarketresearch.com/cardiac-medical-devices-market-in-the-us-2016-2020-market-report.html.

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact:
Ritesh Tiwari
2nd floor, Metropole,
Next to Inox theatre, Bund garden road,
Pune-411001
Maharashtra,India.
+ 1 888 391 5441
sales@rnrmarketresearch.com

© 2016 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.